Safety and Efficacy Study of Glufosfamide in Ovarian Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Ovarian Cancer
Interventions
DRUG

Glufosfamide

Trial Locations (10)

29601

Gynecologic Oncology Research & Development, LLC, Greenville

40202

Louisville Oncology Clinical Research Program, Louisville

44718

Gabrail Cancer Center, Canton

46202

Indiana University Cancer Center, Indianapolis

79106

Harrington Cancer Center, Amarillo

85260

Premiere Oncology of Arizona, Scottsdale

85724

Arizona Cancer Center, Tucson

87106

New Mexico Cancer Care Alliance, Albuquerque

92868

UCI Chao Family Comprehensive Cancer Center, Orange

94904

California Cancer Center, Greenbrae

Sponsors
All Listed Sponsors
lead

Eleison Pharmaceuticals LLC.

INDUSTRY